CERVOMED INC. - COMMON

12.53

07-十一月-24 14:59:45

15 分钟延时

股票

-0.31

-2.41%

今日范围

12.43 - 13.30

ISIN

N/A

来源

NASDAQ

CervoMed Announces Presentation of Biomarker Data from the AscenD-LB Phase 2a Trial and Preclinical Data Supporting Potential of Neflamapimod in Tau-Mediated Disease at AD/PD ™ 2024

05 3月 2024 07:00:00 条件 Nasdaq GlobeNewswire
CervoMed to Participate in the BIO CEO and Investor Conference

21 2月 2024 07:00:00 条件 Nasdaq GlobeNewswire
CervoMed Publishes Positive Results from AscenD-LB Phase 2a Trial in Peer-Reviewed Journal that Supports the Therapeutic Potential of Neflamapimod in Dementia with Lewy Bodies

12 2月 2024 07:00:00 条件 Nasdaq GlobeNewswire
CervoMed Announces Appointment of Industry Leader Joshua Boger, Ph.D., as Chair of the Board

07 2月 2024 07:30:00 条件 Nasdaq GlobeNewswire
CervoMed to Participate in the Emerging Growth Conference 67

05 2月 2024 07:00:00 条件 Nasdaq GlobeNewswire
CervoMed to Participate in the Emerging Growth Conference 66

05 1月 2024 07:00:00 条件 Nasdaq GlobeNewswire

<<
<
1
2
>

我同意 NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie 政策, 隐私政策 and 条款与条件.